Who is sponsoring NCT03945422?

NCT03945422 is sponsored by InMode MD Ltd..

What drugs are being tested in NCT03945422?

Interventions in NCT03945422: AccuTite/FaceTite.

What condition does NCT03945422 study?

NCT03945422 studies Premature Jowl and Neck Laxity Following Facialplasty.

Is NCT03945422 still recruiting?

NCT03945422 is currently completed. Last updated 10 January 2022.

Last reviewed 2022-01-10 · How we verify

NCT03945422

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Use of RF in Premature Jowl and Neck Laxity Following Facialplasty

Completed NA Last updated 10 January 2022

What this trial tests

NA trial testing AccuTite/FaceTite in Premature Jowl and Neck Laxity Following Facialplasty in 11 participants. Completed in 18 January 2021.

Timeline

15 April 2019

Primary endpoint
18 January 2021

18 January 2021

Quick facts

Lead sponsor	InMode MD Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	11
Start date	15 April 2019
Primary completion	18 January 2021
Estimated completion	18 January 2021
Sites	1 location across United States

Drugs / interventions tested

AccuTite/FaceTite

Conditions studied

Premature Jowl and Neck Laxity Following Facialplasty — all drugs for Premature Jowl and Neck Laxity Following Facialplasty →

Sponsor

InMode MD Ltd.

Who can join

Adults 40 to 80, any sex, with Premature Jowl and Neck Laxity Following Facialplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study is to evaluate the efficacy of treatment Radio Frequency in premature jowl and neck laxity following facialplasty

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other InMode MD Ltd. trials

Trials by the same sponsor.

NCT07209397 — Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women · NA · recruiting
NCT06283498 — Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive Bladder · NA · enrolling by invitation
NCT06458556 — Transvaginal Radiofrequency Ablation for Overactive Bladder · NA · completed
NCT05830968 — Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne · NA · recruiting
NCT06283056 — RF Microneedling With Multi-Depth Targeting Per Insertion for The Treatment of Cellulite · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03945422 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by InMode MD Ltd.
Last refreshed: 10 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03945422.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing